Hirawat Samit
Reporting owner on Forms 3, 4 and 5, CIK 1781290.
Hirawat Samit reported on 2 issuers in 2 filings, the latest a Form 4 filed 2026-11-17.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| PCRX · Pacira BioSciences, Inc.CIK 1396814 | director | 1 | 2026-11-17 |
| Iambic Therapeutics, Inc. CIK 1997038 | director | 1 | 2026-10-14 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| PCRX · Pacira BioSciences, Inc.Common Stock | 2026-11-17 | D returned to the issuer | -6,405 | $36.5 | 0 | Form 4 |
| PCRX · Pacira BioSciences, Inc.Stock Option (Right to Buy), derivative | 2026-11-17 | D returned to the issuer | -10,891 | 0 | Form 4 | |
| PCRX · Pacira BioSciences, Inc.Stock Option (Right to Buy), derivative | 2026-11-17 | D returned to the issuer | -39,291 | 0 | Form 4 | |
| Iambic Therapeutics, Inc. Stock Option (right to buy), derivative, holding | Form 3 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001628280-26-074538 | Pacira BioSciences, Inc. | 2026-11-17 | ||
| Form 3 0001781290-26-000003 | Iambic Therapeutics, Inc. | 2026-10-14 |